| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Protection against lipopolysaccharide-induced sepsis and inhibition of interleukin-1beta and prostaglandin E2 synthesis by silymarin.
|
Biochem Pharmacol
|
2004
|
1.10
|
|
2
|
Antitumor activity of cytokine-induced killer cells against human lung cancer.
|
Int Immunopharmacol
|
2007
|
1.01
|
|
3
|
Aryl hydrocarbon receptor-dependent inhibition of AP-1 activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin in activated B cells.
|
Toxicol Appl Pharmacol
|
2002
|
0.98
|
|
4
|
Antagonism of aryl hydrocarbon receptor-dependent induction of CYP1A1 and inhibition of IgM expression by di-ortho-substituted polychlorinated biphenyls.
|
Toxicol Appl Pharmacol
|
2003
|
0.96
|
|
5
|
Inhibition of human ovarian tumor growth by cytokine-induced killer cells.
|
Arch Pharm Res
|
2007
|
0.95
|
|
6
|
Anti-tumor activity of ex vivo expanded cytokine-induced killer cells against human hepatocellular carcinoma.
|
Int Immunopharmacol
|
2007
|
0.94
|
|
7
|
Lactoferrin works as a new LPS-binding protein in inflammatory activation of macrophages.
|
Int Immunopharmacol
|
2004
|
0.91
|
|
8
|
Silymarin inhibits TNF-alpha-induced expression of adhesion molecules in human umbilical vein endothelial cells.
|
FEBS Lett
|
2003
|
0.91
|
|
9
|
Inhibition of atopic dermatitis by topical application of silymarin in NC/Nga mice.
|
Int Immunopharmacol
|
2008
|
0.89
|
|
10
|
Actin-sequestering protein, thymosin-beta-4 (TB4), inhibits caspase-3 activation in paclitaxel-induced tumor cell death.
|
Oncol Res
|
2007
|
0.85
|
|
11
|
Inhibition of atopic dermatitis-like skin lesions by topical application of a novel ceramide derivative, K6PC-9p, in NC/Nga mice.
|
Exp Dermatol
|
2008
|
0.84
|
|
12
|
Topical application of silymarin reduces chemical-induced irritant contact dermatitis in BALB/c mice.
|
Int Immunopharmacol
|
2007
|
0.83
|
|
13
|
Paclitaxel induces vascular endothelial growth factor expression through reactive oxygen species production.
|
Pharmacology
|
2008
|
0.83
|
|
14
|
Hypoxia-inducible transcription factor (HIF)-1 alpha stabilization by actin-sequestering protein, thymosin beta-4 (TB4) in Hela cervical tumor cells.
|
Cancer Lett
|
2008
|
0.83
|
|
15
|
Inhibition of inducible nitric-oxide synthase expression by silymarin in lipopolysaccharide-stimulated macrophages.
|
J Pharmacol Exp Ther
|
2002
|
0.82
|
|
16
|
Differential role of peroxiredoxin II (PrxII) on the expression of toll-like receptor 4 (TLR4) and B-cell activating factor (BAFF) in ovalbumin (OVA)-induced mouse asthma.
|
Int Immunopharmacol
|
2008
|
0.79
|
|
17
|
Formation of distinct inclusion bodies by inhibition of ubiquitin-proteasome and autophagy-lysosome pathways.
|
Biochem Biophys Res Commun
|
2010
|
0.77
|
|
18
|
Topical application of a novel ceramide derivative, K6PC-9, inhibits dust mite extract-induced atopic dermatitis-like skin lesions in NC/Nga mice.
|
Int Immunopharmacol
|
2007
|
0.75
|
|
19
|
2-Acetylaminofluorene inhibits interleukin-1beta production in LPS-stimulated macrophages by blocking NF-kappaB/Rel activation.
|
Cancer Lett
|
2004
|
0.75
|